These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 18678882)
1. Increased 5-lipoxygenase immunoreactivity in the hippocampus of patients with Alzheimer's disease. Ikonomovic MD; Abrahamson EE; Uz T; Manev H; Dekosky ST J Histochem Cytochem; 2008 Dec; 56(12):1065-73. PubMed ID: 18678882 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of hippocampal butyrylcholinesterase: Implications for regional vulnerability in Alzheimer's disease. Mizukami K; Akatsu H; Abrahamson EE; Mi Z; Ikonomovic MD Neuropathology; 2016 Apr; 36(2):135-45. PubMed ID: 26293308 [TBL] [Abstract][Full Text] [Related]
3. Activation of caspase-6 in aging and mild cognitive impairment. Albrecht S; Bourdeau M; Bennett D; Mufson EJ; Bhattacharjee M; LeBlanc AC Am J Pathol; 2007 Apr; 170(4):1200-9. PubMed ID: 17392160 [TBL] [Abstract][Full Text] [Related]
4. Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain. Rohn TT; Rissman RA; Davis MC; Kim YE; Cotman CW; Head E Neurobiol Dis; 2002 Nov; 11(2):341-54. PubMed ID: 12505426 [TBL] [Abstract][Full Text] [Related]
6. Calcineurin (phosphatase 2B) is present in neurons containing neurofibrillary tangles and in a subset of senile plaques in Alzheimer's disease. Brion JP; Couck AM; Conreur JL Neurodegeneration; 1995 Mar; 4(1):13-21. PubMed ID: 7600182 [TBL] [Abstract][Full Text] [Related]
7. [Alzheimer disease: cellular and molecular aspects]. Octave JN Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248 [TBL] [Abstract][Full Text] [Related]
8. Relationship between apolipoprotein E and the amyloid deposits and dystrophic neurites of Alzheimer's disease. Dickson TC; Saunders HL; Vickers JC Neuropathol Appl Neurobiol; 1997 Dec; 23(6):483-91. PubMed ID: 9460714 [TBL] [Abstract][Full Text] [Related]
9. Differential expression of phosphorylated translation initiation factor 2 alpha in Alzheimer's disease and Creutzfeldt-Jakob's disease. Ferrer I Neuropathol Appl Neurobiol; 2002 Dec; 28(6):441-51. PubMed ID: 12445160 [TBL] [Abstract][Full Text] [Related]
10. The expression of calcium/calmodulin-dependent protein kinase II-alpha in the hippocampus of patients with Alzheimer's disease and its links with AD-related pathology. Wang YJ; Chen GH; Hu XY; Lu YP; Zhou JN; Liu RY Brain Res; 2005 Jan; 1031(1):101-8. PubMed ID: 15621017 [TBL] [Abstract][Full Text] [Related]
11. Extracellular signal regulated kinases. Localization of protein and mRNA in the human hippocampal formation in Alzheimer's disease. Hyman BT; Elvhage TE; Reiter J Am J Pathol; 1994 Mar; 144(3):565-72. PubMed ID: 8129042 [TBL] [Abstract][Full Text] [Related]
12. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome. Snow AD; Mar H; Nochlin D; Sekiguchi RT; Kimata K; Koike Y; Wight TN Am J Pathol; 1990 Nov; 137(5):1253-70. PubMed ID: 2146882 [TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls. Han SH; Hulette C; Saunders AM; Einstein G; Pericak-Vance M; Strittmatter WJ; Roses AD; Schmechel DE Exp Neurol; 1994 Jul; 128(1):13-26. PubMed ID: 8070517 [TBL] [Abstract][Full Text] [Related]
14. Association of adipocyte enhancer-binding protein 1 with Alzheimer's disease pathology in human hippocampi. Shijo M; Honda H; Suzuki SO; Hamasaki H; Hokama M; Abolhassani N; Nakabeppu Y; Ninomiya T; Kitazono T; Iwaki T Brain Pathol; 2018 Jan; 28(1):58-71. PubMed ID: 27997051 [TBL] [Abstract][Full Text] [Related]
15. P38 MAP kinase is activated at early stages in Alzheimer's disease brain. Sun A; Liu M; Nguyen XV; Bing G Exp Neurol; 2003 Oct; 183(2):394-405. PubMed ID: 14552880 [TBL] [Abstract][Full Text] [Related]
16. Inducible nitric oxide synthase immunoreactivity in the Alzheimer disease hippocampus: association with Hirano bodies, neurofibrillary tangles, and senile plaques. Lee SC; Zhao ML; Hirano A; Dickson DW J Neuropathol Exp Neurol; 1999 Nov; 58(11):1163-9. PubMed ID: 10560659 [TBL] [Abstract][Full Text] [Related]
17. Transglutaminases and transglutaminase-catalyzed cross-links colocalize with the pathological lesions in Alzheimer's disease brain. Wilhelmus MM; Grunberg SC; Bol JG; van Dam AM; Hoozemans JJ; Rozemuller AJ; Drukarch B Brain Pathol; 2009 Oct; 19(4):612-22. PubMed ID: 18673368 [TBL] [Abstract][Full Text] [Related]
18. Differential involvement of protein kinase C isozymes in Alzheimer's disease. Masliah E; Cole G; Shimohama S; Hansen L; DeTeresa R; Terry RD; Saitoh T J Neurosci; 1990 Jul; 10(7):2113-24. PubMed ID: 2376771 [TBL] [Abstract][Full Text] [Related]
19. Aluminum modifies the properties of Alzheimer's disease PHF tau proteins in vivo and in vitro. Shin RW; Lee VM; Trojanowski JQ J Neurosci; 1994 Nov; 14(11 Pt 2):7221-33. PubMed ID: 7525898 [TBL] [Abstract][Full Text] [Related]
20. Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury. Ikonomovic MD; Uryu K; Abrahamson EE; Ciallella JR; Trojanowski JQ; Lee VM; Clark RS; Marion DW; Wisniewski SR; DeKosky ST Exp Neurol; 2004 Nov; 190(1):192-203. PubMed ID: 15473992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]